Our vision is to be the accepted PAIONeer in sedation and anesthesia; helping advance patient care.
PAION AG grants license to YICHANG Humanwell for Remimazolam in China
PAION Receives Euro 20 Million for Sale of Remaining Desmoteplase Rights to H. Lundbeck A/S
Some of them are essential and required for running the website. Others improve your user experience and may be activated or deactivated at your discretion.